Table 2 Comparison of macular retinal parameters between healthy controls and patients with CPACG.

From: Longitudinal quantitative assessment of macular retinal and choroidal remodeling after trabeculectomy in chronic primary angle-closure glaucoma using ultra-widefield SS-OCTA

Regional Variables

Healthy Controls (n = 42)

CPACG Group (n = 40)

P-value

Regional SVD values

Mean

48.00 ± 1.43

45.82 ± 2.04

< 0.001***

Circle 0–1 mm

C1

48.21 ± 2.97

45.85 ± 2.74

< 0.001***

Circle 1–3 mm

T3

48.00 (46.75, 51.00)

46.00 (45.00, 47.75)

< 0.001***

S3

47.00 (45.00, 49.25)

45.00 (43.25, 47.00)

0.004**

N3

46.00 (45.00, 48.25)

45.00 (42.00, 47.00)

0.004**

I3

48.17 ± 2.05

45.63 ± 2.76

< 0.001***

Circle 3–6 mm

T6

48.64 ± 1.79

46.58 ± 2.94

< 0.001***

S6

47.00 (46.00, 48.00)

46.00 (44.00, 47.00)

0.003**

N6

49.00 (47.75, 50.00)

47.00 (45.00, 49.00)

0.013*

I6

48.00 (47.00, 49.00)

46.00 (44.25, 47.00)

< 0.001***

Regional GCC Thickness values

Mean

100.51 ± 2.70

95.02 ± 5.70

< 0.001***

Circle 0–1 mm

C1

67.86 ± 7.72

64.18 ± 5.15

0.013*

Circle 1–3 mm

T3

116.55 ± 13.14

110.25 ± 11.43

0.023*

S3

122.33 ± 8.35

116.50 ± 12.20

0.013*

N3

124.55 ± 12.10

119.35 ± 19.41

0.147

I3

124.00 (114.00, 130.00)

112.00 (106.00, 115.75)

< 0.001***

Circle 3–6 mm

T6

105.74 ± 8.78

98.60 ± 11.40

0.002**

S6

115.21 ± 11.03

109.30 ± 10.45

0.015*

N6

118.64 ± 9.87

116.13 ± 19.02

0.451

I6

111.07 ± 11.39

102.65 ± 7.58

< 0.001***

  1. Note: * indicates a statistically significant difference between the healthy controls and the CPACG group. *P < 0.05, **P < 0.01, ***P < 0.001.